• Ven. Nov 22nd, 2024

survival

  • Home
  • Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease #ESMO24

Gynaecological Cancers: Immunotherapy and Novel Targeted Drug Appear Beneficial in Group of Women with Early-Stage Disease #ESMO24

Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial (1) and cervical cancers (2) who gain clinically meaningful benefit from adding immunotherapy to current standard treatments,…

Long-term results from Testicular Cancer treatment are positive

A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even after first-line treatment fails. . The recent study published in the…

Linfoma, novita’ terapie Roche al Congresso dell’Associazione Europea di Ematologia #EHA24

Roche ha annunciato risultati statisticamente e clinicamente significativi dello studio di Fase III STARGLO relativi alla combinazione glofitamab + gemcitabina e oxaliplatino (GemOx) rispetto alla combinazione rituximab e GemOX, nei…

Gene therapy is halting cancer. Can it work against brain tumors?

Grant of up to $11 million will fund a clinical trial at UCSF that uses a smarter new CAR-T guided by precision technology. A type of gene therapy called CAR-T…